Last reviewed · How we verify
Placebo (matched to ivacaftor) — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo (matched to ivacaftor) (Placebo (matched to ivacaftor)) — Vertex Pharmaceuticals Incorporated. This drug has no therapeutic effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo (matched to ivacaftor) TARGET | Placebo (matched to ivacaftor) | Vertex Pharmaceuticals Incorporated | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo (matched to ivacaftor) CI watch — RSS
- Placebo (matched to ivacaftor) CI watch — Atom
- Placebo (matched to ivacaftor) CI watch — JSON
- Placebo (matched to ivacaftor) alone — RSS
Cite this brief
Drug Landscape (2026). Placebo (matched to ivacaftor) — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-matched-to-ivacaftor. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab